Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Continuous Lidocaine in Elective Primary Tumor Craniotomy
NCT06249113Completed
- Sponsor
- Universitas Indonesia
- Start
- Jan 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in Intraoperative pain (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Depth of Anesthesia (qCON), Pain Response (qNOX) and 1 more. Started Jan 2023; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Intraoperative pain
Beyond the preview
Go deeper on NCT06249113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06249113.